Create issue ticket

1,747 Possible Causes for Pulmonary, Vasodilation, Venous

  • Pulmonary Veno-Occlusive Disease

    Abstract A patient presenting with the rare association of congenital unilateral pulmonary venous atresia in one lung and pulmonary veno-occlusive disease in the other is[] KEYWORDS: Genetics; Pulmonary capillary hemangiomatosis; Pulmonary disorder; Pulmonary hypertension; Pulmonary veno-occlusive disease Publication type, MeSH terms, Substances[] Details of the vasodilator studies, and the rationale for treating this uncommon disorder, are provided.[]

  • Acute Bronchitis

    CHF Patients with CHF may cough but also have other symptoms and signs such as dyspnea on exertion, orthopnea, rales on lung examination, peripheral edema, raised jugular venous[] Differentiation of cough-variant asthma may require pulmonary function testing.[] View Article PubMed Google Scholar Yamazaki F: Hyperoxia attenuates endothelial-mediated vasodilation in the human skin.[]

  • Pulmonary Hypertension

    In this full-text version, we present a more detailed discussion of sinus-venous atrial septal defect associated with partial anomalous pulmonary venous return that was wrongly[] Chronic thromboembolic pulmonary hypertension and other pulmonary artery obstructions.[] Epoprostenol is a naturally occurring prostaglandin and potent vasodilator. It affects vascular remodelling and inhibits platelet aggregation.[]

  • Hepatopulmonary Syndrome

    Right-to-left shunt associated with microscopic pulmonary arterial venous malformations (PAVMs) secondary to hepatopulmonary syndrome (HPS).[] The pulmonary vascular responses to hypoxia examined before and after the spontaneous resolution of HPS confirmed that the pathogenesis of HPS could be functional and reversible[] Moderate portopulmonary hypertension, which is a contraindication to a liver transplant, must be managed with pulmonary vasodilators to normalize pulmonary arterial pressures[]

  • Low Cardiac Output

    The diagnostic values were not improved by using instead central venous O(2) tension or the difference between arterial and central venous O(2) saturation.[] Pulmonary hypertension is among the causes of low cardiac output syndrome after neonatal and pediatric cardiac surgery.[] OBJECTIVES: To determine the effects in terms of efficacy, efficiency and safety of cardiac care with inotropic agents and vasodilator strategies versus placebo or against[]

  • Secondary Pulmonary Hypertension

    An echocardiogram revealed secondary pulmonary hypertension due to pulmonary venous obstruction.[] This may be important in the future if new specific therapies for primary pulmonary hypertension are shown to be beneficial in secondary pulmonary hypertension.[] The vasodilators were compared in respect to their ability to decrease mPAP and the unwanted increase in AUCSaO2.[]

  • Treprostinil

    Central venous access was via the cephalic, subclavian, jugular, or axillary vein.[] , and quality of life in patients with pulmonary arterial hypertension, an uncommon disease of poor prognosis.[] In the present study, objectives were to determine whether EPC may contribute to vasodilator treatment efficacy in PAH.[]

  • Vasodilator

    The net effect is site-specific, resulting in a selective venous vasodilator action. This may exacerbate unwanted venous pooling during postoperative pain therapy.[] Abstract Primary pulmonary hypertension is a rare disease of childhood, which carries a poor prognosis.[] Calcium channel blockers promote peripheral vasodilation and reduce vascular resistance.[]

  • Epoprostenol

    Intrapulmonary shunting was confirmed by contrast echocardiography showing delayed appearance of bubbles in the left cardiac chambers after peripheral venous injection of[] Abstract Vascular remodeling of distal pulmonary arterioles that promotes abnormal pulmonary vascular reactivity is a central mechanism in the pathogenesis of pulmonary arterial[] Both prostaglandin E1 and epoprostenol were effective vasodilators: 5 ng/kg/min of epoprostenol was equivalent to 30 ng/kg/min of prostaglandin E1.[]

  • Idiopathic Pulmonary Fibrosis

    Here we describe the successful management of an IPF patient with acute respiratory failure (ARF) using a pump-assisted veno-venous system for extracorporeal CO2 removal ([] pulmonary rehabilitation have been shown.[] Since nitric oxide is a potent pulmonary vasodilator, reduced levels are associated with pulmonary vasoconstriction and impaired gas exchange. 4 Sildenafil (Revatio, Pfizer[]